公开(公告)号：EP2412242A2

公开(公告)日：2012-02-01

申请号：EP11161076.2

申请日：2002-07-05

申请人： Novartis Vaccines and Diagnostics, Inc. ,  University of Stellenbosch

发明人： Zur Megede, Jan ,  Barnett, Susan W. ,  Lian, Ying ,  Engelbrecht, Susan ,  Van Rensburg, Estrelita Janse ,  Scriba, Thomas Jens

IPC分类号： A01N63/00 ,  A61K48/00 ,  C12N5/00 ,  C12N5/02 ,  C12N15/00 ,  C12N15/09 ,  C12N15/63 ,  C12N15/70 ,  C12N15/74 ,  C07H21/04 ,  C07K14/16 ,  C12N15/867

CPC分类号： C07K14/005 ,  A61K39/00 ,  A61K39/12 ,  A61K39/21 ,  A61K2039/53 ,  C12N15/86 ,  C12N2720/00034 ,  C12N2740/16043 ,  C12N2740/16052 ,  C12N2740/16122 ,  C12N2740/16222 ,  C12N2740/16322 ,  C12N2799/027 ,  C12N2800/108 ,  C12N2830/42 ,  C12N2840/203

摘要： The present invention relates to polynucleotides encoding immunogenic HIV polypeptides. Uses of the polynucleotides in applications including immunization, generation of packaging cell lines, and production of HIV polypeptides are also described. Polynucleotides encoding antigenic HIV polypeptides are described, as are uses of these polynucleotides and polypeptide products therefrom, including formulations of immunogenic compositions and uses thereof.

摘要翻译： 本发明涉及编码免疫原性HIV多肽的多核苷酸。 还描述了多核苷酸在包括免疫接种，包装细胞系产生和HIV多肽产生在内的应用中的用途。 描述了编码抗原性HIV多肽的多核苷酸，以及这些多核苷酸及其多肽产物的用途，包括免疫原性组合物的制剂及其用途。

公开(公告)号：EP2412242A3

公开(公告)日：2012-06-13

申请号：EP11161076.2

申请日：2002-07-05

申请人： Novartis Vaccines and Diagnostics, Inc. ,  University of Stellenbosch

发明人： Zur Megede, Jan ,  Barnett, Susan W. ,  Lian, Ying ,  Engelbrecht, Susan ,  Van Rensburg, Estrelita Janse ,  Scriba, Thomas Jens

IPC分类号： A01N63/00 ,  A61K48/00 ,  C12N5/00 ,  C12N5/02 ,  C12N15/00 ,  C12N15/09 ,  C12N15/63 ,  C12N15/70 ,  C12N15/74 ,  C07H21/04 ,  C07K14/16 ,  C12N15/867 ,  C07K14/005 ,  C12N15/86

CPC分类号： C07K14/005 ,  A61K39/00 ,  A61K39/12 ,  A61K39/21 ,  A61K2039/53 ,  C12N15/86 ,  C12N2720/00034 ,  C12N2740/16043 ,  C12N2740/16052 ,  C12N2740/16122 ,  C12N2740/16222 ,  C12N2740/16322 ,  C12N2799/027 ,  C12N2800/108 ,  C12N2830/42 ,  C12N2840/203

摘要： The present invention relates to polynucleotides encoding immunogenic HIV polypeptides. Uses of the polynucleotides in applications including immunization, generation of packaging cell lines, and production of HIV polypeptides are also described. Polynucleotides encoding antigenic HIV polypeptides are described, as are uses of these polynucleotides and polypeptide products therefrom, including formulations of immunogenic compositions and uses thereof.